|
Volumn 324, Issue 7339, 2002, Pages 714-718
|
Science, medicine, and the future: Cancer chemoprevention
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3 INDOLEMETHANOL;
ALITRETINOIN;
ALPHA TOCOPHEROL;
BEXAROTENE;
BICALUTAMIDE;
CALCIUM;
CELECOXIB;
CURCUMIN;
EFLORNITHINE;
EXEMESTANE;
FENRETINIDE;
FLUTAMIDE;
FOLIC ACID;
ISOFLAVONE;
LEUPRORELIN;
LYCOPENE;
MEDROXYPROGESTERONE ACETATE;
OLTIPRAZ;
ORAL CONTRACEPTIVE AGENT;
PERILLYL ALCOHOL;
PHENETHYL ISOTHIOCYANATE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
SELENOMETHIONINE;
SOYBEAN OIL;
SULINDAC;
TAMOXIFEN;
TOREMIFENE;
TUMOR MARKER;
UNINDEXED DRUG;
VITAMIN D;
ANTINEOPLASTIC AGENT;
CANCER PREVENTION;
CANCER THERAPY;
CARCINOGENESIS;
CHEMOPROPHYLAXIS;
DIET SUPPLEMENTATION;
DIET THERAPY;
HIGH RISK PATIENT;
PRIORITY JOURNAL;
REVIEW;
VALIDATION PROCESS;
CLINICAL TRIAL;
HUMAN;
NEOPLASM;
TREATMENT OUTCOME;
ANTICARCINOGENIC AGENTS;
CLINICAL TRIALS;
HUMANS;
NEOPLASMS;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0037160923
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.324.7339.714 Document Type: Review |
Times cited : (120)
|
References (27)
|